01 AUROBINDO PHARMA LIMITED Hyderabad IN (1)
02 Artemis Biotech (A Division of Themis Medicare Limited) Hyderabad IN (3)
03 BIOCON LIMITED Bangalore IN (2)
04 BIOCON LIMITED Bengaluru IN (2)
05 CONCORD BIOTECH LIMITED Ahmedabad IN (1)
06 HENAN TOPFOND SCI-TECH CO., LTD. Zhumadian CN (2)
07 HETERO LABS LIMITED Hyderabad IN (1)
08 HOVIONE FARMACIENCIA S.A. Loures PT (1)
09 JUBILANT PHARMOVA LIMITED Nanjangud IN (1)
10 KREBS BIOCHEMICALS & INDUSTRIES LIMITED Kothapalli IN (2)
11 KRKA, d.d., Novo mesto Novo mesto SI (2)
12 LEK PHARMACEUTICALS D.D. Ljubljana SI (1)
13 LUPIN LIMITED Mumbai IN (1)
14 Merck Sharp & Dohme (Europe) Inc. Brussels BE (1)
15 SHANGYU JINGXIN PHARMACEUTICAL CO., LTD. Shangyu CN (1)
16 SHAOXING JINGXIN PHARMACEUTICAL CO., LTD. Shangyu CN (1)
17 SOUTHWEST SYNTHETIC PHARMACEUTICAL CORPORATION, LIMITED Chongqing CN (1)
18 STERLING BIOTECH LIMITED Masar Village IN (1)
19 SUN PHARMACEUTICAL INDUSTRIES LIMITED Mumbai IN (1)
20 Sandoz Industrial Products SpA Rovereto IT (1)
21 TEVA PHARMACEUTICAL INDUSTRIES LTD Petach Tikva IL (1)
22 TEVA PHARMACEUTICAL INDUSTRIES LTD Tel Aviv - Jaffa IL (4)
23 ZHEJIANG APELOA KANGYU PHARMACEUTICAL CO., LTD. Hengdian CN (1)
24 ZHEJIANG JIANGBEI NANHAI PHARMACEUTICAL CO., LTD Linhai City CN (2)
25 ZHEJIANG JIANGBEI PHARMACEUTICAL CO., LTD. Taizhou City CN (4)
26 Zhejiang Hisun Pharmaceutical Co., Ltd. Taizhou City CN (2)
01 Simvastatin (23)
02 Simvastatin, Antioxidant Butylated Hydroxy Toluene 0.01% (1)
03 Simvastatin, Antioxidant butylated hydroxyanisole (1)
04 Simvastatin, Antioxidant butylhydroxyanisole (1)
05 Simvastatin, BHA process (1)
06 Simvastatin, Butylated Hydroxy Anisole 50 - 150 ppm (1)
07 Simvastatin, Butylated Hydroxyanisole 0.01% (2)
08 Simvastatin, Butylated hydroxy anisole 0.18-0.22% (1)
09 Simvastatin, Butylated hydroxyanisole 0.01%, Process II (1)
10 Simvastatin, Ethanol II process (1)
11 Simvastatin, Ethanol process (1)
12 Simvastatin, Ethanol/acetonitrile process (1)
13 Simvastatin, Ethanol/acetonitrile/BHA process (1)
14 Simvastatin, Process II (1)
15 Simvastatin, Process II, with butylated hydroxyanisole 0.010% (1)
16 Simvastatin, With butylated hydroxyanisole (1)
17 Simvastatin, With butylated hydroxyanisole 0.010% (1)
18 Simvastatin, with 0.2% butylated hydroxy anisole (1)
01 Brazil (1)
02 China (14)
03 Germany (1)
04 India (16)
05 Israel (5)
06 Portugal (1)
07 Slovenia (3)
01 Expired (2)
02 Valid (26)
03 Withdrawn by EDQM Failure to CEP procedure (1)
04 Withdrawn by Holder (12)
35
PharmaCompass offers a list of Simvastatin API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Simvastatin manufacturer or Simvastatin supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Simvastatin manufacturer or Simvastatin supplier.
PharmaCompass also assists you with knowing the Simvastatin API Price utilized in the formulation of products. Simvastatin API Price is not always fixed or binding as the Simvastatin Price is obtained through a variety of data sources. The Simvastatin Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A DSSTox_CID_3581 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of DSSTox_CID_3581, including repackagers and relabelers. The FDA regulates DSSTox_CID_3581 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. DSSTox_CID_3581 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of DSSTox_CID_3581 manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A DSSTox_CID_3581 supplier is an individual or a company that provides DSSTox_CID_3581 active pharmaceutical ingredient (API) or DSSTox_CID_3581 finished formulations upon request. The DSSTox_CID_3581 suppliers may include DSSTox_CID_3581 API manufacturers, exporters, distributors and traders.
click here to find a list of DSSTox_CID_3581 suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A DSSTox_CID_3581 CEP of the European Pharmacopoeia monograph is often referred to as a DSSTox_CID_3581 Certificate of Suitability (COS). The purpose of a DSSTox_CID_3581 CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of DSSTox_CID_3581 EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of DSSTox_CID_3581 to their clients by showing that a DSSTox_CID_3581 CEP has been issued for it. The manufacturer submits a DSSTox_CID_3581 CEP (COS) as part of the market authorization procedure, and it takes on the role of a DSSTox_CID_3581 CEP holder for the record. Additionally, the data presented in the DSSTox_CID_3581 CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the DSSTox_CID_3581 DMF.
A DSSTox_CID_3581 CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. DSSTox_CID_3581 CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of DSSTox_CID_3581 suppliers with CEP (COS) on PharmaCompass.
We have 22 companies offering DSSTox_CID_3581
Get in contact with the supplier of your choice: